SCHEMBL23655797

SCHEMBL23655797

CCCCC/C=C\C=C\CCCCCCCCOc1cc(C(=O)OCCCCCCCC/C=C\CCCCCCCC)cc(OCCCCCCCC/C=C\C/C=C\CCCCC)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 4/20 0.49
▸ AKR1C3 P42330 2/20 0.49
▸ AKR1C4 P17516 1/20 0.49
▸ AKR1C2 P52895 1/20 0.49
▸ AKR1C1 Q04828 1/20 0.49
▸ ALDH1A1 P00352 4/20 0.44
▸ F7 P08709 3/20 0.44
▸ F3 P13726 3/20 0.44
▸ PPARG P37231 2/20 0.44
▸ PPARD Q03181 2/20 0.44
▸ PPARA Q07869 2/20 0.44
▸ DUSP3 P51452 1/20 0.44
▸ PTPN7 P35236 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ FFAR1 O14842 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ FABP3 P05413 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP19A1 P11511 1/20 0.44
▸ FABP4 P15090 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17685812 0.96 ESR1 (0.52) ESR1AKR1C3AKR1C4AKR1C2AKR1C1
SCHEMBL21698664 0.96 ESR1 (0.52) ESR1AKR1C3AKR1C4AKR1C2AKR1C1
SCHEMBL16154809 0.96 ESR1 (0.52) ESR1AKR1C3AKR1C4AKR1C2AKR1C1
SCHEMBL16012923 0.89 ESR1 (0.45) ESR1AKR1C3AKR1C4AKR1C2AKR1C1
SCHEMBL21300622 0.89 ESR1 (0.45) ESR1AKR1C3AKR1C4AKR1C2AKR1C1
SCHEMBL16012922 0.89 ESR1 (0.45) ESR1AKR1C3AKR1C4AKR1C2AKR1C1
SCHEMBL16012945 0.88 ESR1 (0.43) ESR1AKR1C3AKR1C4AKR1C2AKR1C1
SCHEMBL16012946 0.88 ESR1 (0.43) ESR1AKR1C3AKR1C4AKR1C2AKR1C1
SCHEMBL17685721 0.85 PLA2G2A (0.55) ESR1AKR1C3ALDH1A1F7F3
SCHEMBL16154810 0.85 PLA2G2A (0.55) ESR1AKR1C3ALDH1A1F7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3608308-B1 LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS NOVARTIS AG (CH) 2021-07-21 — — EP disclosed
Send feedback